IPO - CALLAN JMB INC.

Form Type: SCHEDULE 13G

Filing Date: 2025-02-10

Corporate Action: Ipo

Type: New

Accession Number: 000175392625000195

Filing Summary: Callan JMB Inc. filed a Schedule 13G regarding its ownership of Common Stock following its initial public offering (IPO) of 4,280,000 shares. Ionic Ventures, LLC, beneficially owns 233,725 shares, which represents 5.5% of the total shares outstanding. The reporting persons, including Ionic Ventures, Ionic Management, Brendan O'Neil, and Keith Coulston, have agreed to jointly file this schedule. The document details the beneficial ownership and voting power amongst these individuals and entities, noting that Mr. O'Neil and Mr. Coulston do not directly own shares but may be deemed to beneficially own the shares owned by Ionic and Ionic Management due to their managerial roles.

Form Type: 8-K

Filing Date: 2025-02-07

Corporate Action: Ipo

Type: New

Accession Number: 000149315225005461

Filing Summary: On February 4, 2025, Callan JMB Inc. entered into an Underwriting Agreement with Alexander Capital L.P. for its initial public offering (IPO) of 1,280,000 shares of common stock at an offering price of $4.00 per share. The underwriters received a 45-day option to purchase an additional 192,000 shares. The offering was conducted under the Registration Statement filed with the SEC and was declared effective on February 4, 2025, with shares commencing trading on The Nasdaq Capital Market on February 5, 2025, under the symbol 'CJMB'. Net proceeds from the offering were approximately $4.1 million after offering expenses. The agreement also included a warrant for the underwriters to purchase an additional 64,000 shares at $4.80 per share. On February 7, 2025, the underwriters partially exercised their over-allotment option, purchasing an additional 163,569 shares, which generated net proceeds of around $592,000. The company has agreed not to issue additional stock until February 4, 2026, without consent from the representative. On the same day, the company announced the closing of the Partial Over-Allotment via a press release.

Form Type: 424B4

Filing Date: 2025-02-06

Corporate Action: Ipo

Type: New

Accession Number: 000149315225005135

Filing Summary: Callan JMB Inc. is conducting an initial public offering (IPO) of 1,280,000 shares of its common stock at an initial price of $4.00 per share, generating estimated proceeds of approximately $4.68 million before expenses. The common stock, also subject to Underwriters' Warrants allowing for the purchase of an additional 64,000 shares, has been approved for listing on the Nasdaq Capital Market under the symbol “CJMB.” With the execution of the offering, founding members Wayne Williams and Dr. David Croyle will retain approximately 52.6% and 17.5% of voting power, respectively, recognizing Callan JMB as a controlled company under Nasdaq's governance rules. An additional 45-day option for underwriters to purchase up to 192,000 shares to cover over-allotments has been granted. The delivery of shares is expected on February 6, 2025.

Form Type: S-1/A

Filing Date: 2025-01-08

Corporate Action: Ipo

Type: New

Accession Number: 000149315225001375

Filing Summary: Callan JMB Inc. is conducting its initial public offering (IPO) by registering 1,280,000 shares of common stock at an expected price between $4.00 and $6.00 per share. The offer includes warrants for underwriters to purchase up to 64,000 additional shares. The company has applied for listing on Nasdaq under the symbol 'CJMB'. Currently, the company is considered a controlled entity with Wayne Williams, the CEO, holding 75% of shares, while Dr. David Croyle holds 25%. The document outlines Callan JMB as a vertically integrated logistics company specializing in thermal management solutions for the life sciences sector, emphasizing innovative and environmentally responsible operations. It details plans for utilizing advanced predictive technology to maintain the integrity of temperature-sensitive shipments. The prospectus highlights risks associated with the offering and emphasizes Callan JMB's emerging growth status, aiming to leverage technology toward improved efficiency and service delivery in logistics and fulfillment. Additionally, the company focuses on emergency preparedness and innovative packaging solutions as key aspects of their business strategy.